general prnewswire_all 2d ago 0 views

/C O R R E C T I O N -- ShiraTronics, Inc./

In the news release, ShiraTronics Completes Enrollment in RELIEV-CM2 Pivotal Trial of Implantable Extracranial Neuromodulation Systems (IENs) for Chronic Migraine, issued 02-Jun-2026 by ShiraTronics, Inc. over PR Newswire, we are advised by the company that changes have been made. The...
View original →